Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile
Avencia Sanchez-Mejias PhD

@avenciasm

CEO & Co-founder @integra_TX a global leader creating next-generation #GeneWritting tools to make #AdvanceTherapies safer #STEMWomen Yoguini, lactivist, mother

ID: 755941697591181312

linkhttps://integra-tx.com calendar_today21-07-2016 01:45:20

237 Tweet

302 Followers

295 Following

Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

I get inspired every day by the great women scientist at Integra Therapeutics working to make Gene Writing available to patients. International Day of Women and Girls in Science #February11

Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

Por el día mundial de la Mujer y la Niña en Ciencia, mi madre y yo participamos en este editorial de @disruptores_inn sobre búsqueda de referentes para vocaciones #STEM #February11 Detrás de una gran mujer hay un grupo de mujeres aún mejores

Por el día mundial de la Mujer y la Niña en Ciencia, mi madre y yo participamos en este editorial de @disruptores_inn  sobre búsqueda de referentes para vocaciones #STEM

#February11 

Detrás de una gran mujer hay un grupo de mujeres aún mejores
Amadix (@amadixdx) 's Twitter Profile Photo

Hoy #DiadelaMujerylaNiñaenlaciencia Muchas mujeres investigadoras, demasiadas veces olvidadas, dieron grandes saltos que abrieron ventanas de oportunidades para dar respuesta a la tan temida enfermedad: el cáncer. #11F #MujeresReferentes #Científicas #Oncology #CancerHoy👩‍🔬🔬🎗️

Hoy #DiadelaMujerylaNiñaenlaciencia Muchas mujeres investigadoras, demasiadas veces olvidadas, dieron grandes saltos que abrieron ventanas de oportunidades para dar respuesta a la tan temida enfermedad: el cáncer.  #11F #MujeresReferentes #Científicas #Oncology #CancerHoy👩‍🔬🔬🎗️
Integra Therapeutics (@integra_tx) 's Twitter Profile Photo

Today is #RareDiseaseDay. 5% of the global population is currently affected by rare diseases, most of which are genetic. And there is only treatment for 6% of the over 6,000 identified so far. But what if we could change that 🤔?

Today is #RareDiseaseDay. 5% of the global population is currently affected by rare diseases, most of which are genetic. And there is only treatment for 6% of the over 6,000 identified so far.

But what if we could change that 🤔?
Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

We are very excited to participate in this groundbreaking project with to make novel #AdvancedTherapies available for patients. We are thankful for our great partners and funding agencies. Learn more: lnkd.in/d-uiKS6f

Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

I’am so honored to be featured with these amazing women in #syntheticbiology that has been an inspiration for me. I celebrate these and all woman in STEM and in industries that have been male dominated #bethechange #DiaDeLaMujer

Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

I am so lucky to work with the best team! Thank you Paolo Petazzi for your work and compromise with Integra Therapeutics as we advanced FiCAT platform for safer immune cells engineering.

Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

🚀 I will be joining forces with ⁦Daniel Georgiev⁩ and Jake Lesnik at ⁦SynBioBeta⁩ 2024. Don't miss "Gene Meets Cell: The SynBio Evolution in Targeted Therapeutics," where we'll explore the groundbreaking advancements shaping the future of medicine. #SynBioBeta2024

🚀 I will be joining forces with ⁦<a href="/daniel_georgi/">Daniel Georgiev</a>⁩ and Jake Lesnik at ⁦<a href="/SynBioBeta/">SynBioBeta</a>⁩ 2024. Don't miss "Gene Meets Cell: The SynBio Evolution in Targeted Therapeutics," where we'll explore the groundbreaking advancements shaping the future of medicine. #SynBioBeta2024
Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

It was very exciting to participate in this panel discussion at the Main Stage during #SynBioBeta2024 Thanks to John Cumbers and his team for putting together another amazing conference; and to my peer panelist for their insights on the present and future of Targeted Therapeutics

It was very exciting to participate in this panel discussion at the Main Stage during #SynBioBeta2024 Thanks to <a href="/johncumbers/">John Cumbers</a> and his team for putting together another amazing conference; and to my peer panelist for their insights on the present and future of Targeted Therapeutics
Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

Ha sido un placer participar en el #DemoDay del programa #Jump4Women gracias a Foment del Treball Nacional y U.S. Consulate General Barcelona Es un orgullo compartir programa con tantas mujeres que lideran proyectos innovadores en #Biotech #Healthtech y #Deeptech

Ha sido un placer participar en el #DemoDay del programa #Jump4Women gracias a <a href="/FomentTreball/">Foment del Treball Nacional</a> y <a href="/USConsulateBCN/">U.S. Consulate General Barcelona</a> Es un orgullo compartir programa con tantas mujeres que lideran proyectos innovadores en #Biotech #Healthtech y #Deeptech
Avencia Sanchez-Mejias PhD (@avenciasm) 's Twitter Profile Photo

We are very grateful for the support from the European Innovation Council because is a huge impetus for Integra Therapeutics and our #FiCAT advanced therapies platform. I am pleased to see an increased in the #women led companies chosen by #eicAccelerator   #EUeic #STEMWomen #WomenInBusiness

Manuel Ansede (@manuelansede) 's Twitter Profile Photo

Entrevistamos a Ana Crespo, la primera mujer que preside la Real Academia de Ciencias desde su fundación en 1847. Se me ocurrió sobre la marcha preguntarle si había baño de mujeres cuando entró la primera académica en 1986. La respuesta es increíble: elpais.com/ciencia/2024-0…

Entrevistamos a Ana Crespo, la primera mujer que preside la Real Academia de Ciencias desde su fundación en 1847. Se me ocurrió sobre la marcha preguntarle si había baño de mujeres cuando entró la primera académica en 1986. La respuesta es increíble:
elpais.com/ciencia/2024-0…
Integra Therapeutics (@integra_tx) 's Twitter Profile Photo

🧬 Big news for #AdvancedTherapies: CasZyme and Integra Therapeutics sign #licensing agreement for novel #CRISPR Cas12l nucleases. Today at #BIOEurope in Stockholm bit.ly/4en3OEU 📷 Dr Monika Paule, CEO of Caszyme, and Dr Avencia Sanchez-Mejias PhD, CEO of Integra #GeneWriting #FiCAT

🧬 Big news for #AdvancedTherapies: <a href="/caszyme/">CasZyme</a> and Integra Therapeutics sign #licensing agreement for novel #CRISPR Cas12l nucleases. Today at #BIOEurope in Stockholm bit.ly/4en3OEU

📷 Dr Monika Paule, CEO of Caszyme, and Dr <a href="/avenciasm/">Avencia Sanchez-Mejias PhD</a>, CEO of Integra

#GeneWriting #FiCAT
Punto Europeo de Ciudadanía (@puntoeuropeoes) 's Twitter Profile Photo

El European Prize for Women Innovators 2025 del European Institute of Innovation & Technology reconoce a 19 mujeres emprendedoras que están transformando sectores clave en Europa, entre ellas, las españolas Agnès Arbat, Avencia Sanchez-Mejias PhD y Thais Maria Glod Nuñez.  📌 Lista completa 👉 s.mtrbio.com/jmgjojiaul #WiPrizeEu

El European Prize for Women Innovators 2025 del <a href="/EITeu/">European Institute of Innovation & Technology</a> reconoce a 19 mujeres emprendedoras que están transformando sectores clave en Europa, entre ellas, las españolas <a href="/ArbatAgnes/">Agnès Arbat</a>, <a href="/avenciasm/">Avencia Sanchez-Mejias PhD</a> y Thais Maria Glod Nuñez. 
📌 Lista completa 👉 s.mtrbio.com/jmgjojiaul
#WiPrizeEu